Institutional shares held 12.2 Million
12K calls
23.4K puts
Total value of holdings $111M
$109K calls
$213K puts
Market Cap $164M
18,023,100 Shares Out.
Institutional ownership 67.59%
# of Institutions 92


Latest Institutional Activity in OPRX

Top Purchases

Q1 2025
Janney Montgomery Scott LLC Shares Held: 125K ($1.14M)
Q1 2025
Calamos Advisors LLC Shares Held: 33.4K ($305K)
Q1 2025
Rhumbline Advisers Shares Held: 27.8K ($253K)
Q1 2025
Versant Capital Management, Inc Shares Held: 1.79K ($16.4K)
Q1 2025
Cwm, LLC Shares Held: 685 ($6.25K)

Top Sells

Q1 2025
Sbi Securities Co., Ltd. Shares Held: 373 ($3.4K)
Q1 2025
Gamma Investing LLC Shares Held: 444 ($4.05K)
Q1 2025
Rice Hall James & Associates, LLC Shares Held: 576K ($5.25M)
Q1 2025
Nisa Investment Advisors, LLC Shares Held: 303 ($2.76K)
Q4 2024
Awm Investment Company, Inc. Shares Held: 215K ($1.96M)

About OPRX

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.


Insider Transactions at OPRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
705K Shares
From 22 Insiders
Open market or private purchase 341K shares
Grant, award, or other acquisition 241K shares
Exercise of conversion of derivative security 123K shares
Sell / Disposition
29.6K Shares
From 6 Insiders
Payment of exercise price or tax liability 29.6K shares

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX